A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumorsfor Locally Advanced or Metastatic Malignant Solid TumorsSites in Nashville +3 more locationsSponsor: Astellas Pharma Global Development, Inc.Sex: All·Age: 18+Code: NCT07287995·Phase 1, Phase 2·Recruiting·Listed Dec 2025Apply to this trial
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumorsfor Advanced Solid Tumor, AdultSites in Nashville +5 more locationsSponsor: Cogent Biosciences, Inc.Sex: All·Age: 18+Code: NCT07361562·Phase 1·Recruiting·Listed Jan 2026Apply to this trial
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumorsfor Colorectal NeoplasmsSites in Nashville +3 more locationsSponsor: Janssen Research & Development, LLCSex: All·Age: 18+Code: NCT07107230·Phase 1·Recruiting·Listed Aug 2025Apply to this trial
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphomafor Non-Hodgkin Lymphoma Refractory/ RelapsedSites in Nashville +5 more locationsSponsor: LTZ Therapeutics, Inc.Sex: All·Age: 18+Code: NCT07121946·Phase 1·Recruiting·Listed Aug 2025Apply to this trial
A Phase 1 of CTX-8371 in Patients With Advanced Malignanciesfor Non Small Cell Lung CancerSites in Nashville +8 more locationsSponsor: Compass TherapeuticsSex: All·Age: 18+Code: NCT06150664·Phase 1·Recruiting·Listed Nov 2023Apply to this trial
A Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cellsfor Long Term Safety Following GM T Cell Therapy1 location in NashvilleSponsor: Regeneron PharmaceuticalsSex: All·Age: 18+Code: NCT06798298·Recruiting·Listed Jan 2025Apply to this trial
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myelomafor Relapsed or Refractory Multiple MyelomaSites in Nashville +8 more locationsSponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.Sex: All·Age: 18+Code: NCT06375044·Phase 1·Recruiting·Listed Apr 2024Apply to this trial
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancerfor Ovarian CancerSites in Nashville +4 more locationsSponsor: Nerviano Medical SciencesSex: Female·Age: 18+Code: NCT06930755·Phase 1·Recruiting·Listed Apr 2025Apply to this trial
IKS014 in Advanced Solid Tumors That Express HER2for Breast CancerSites in Nashville +3 more locationsSponsor: Iksuda Therapeutics Ltd.Sex: All·Age: 18+Code: NCT05872295·Phase 1·Recruiting·Listed May 2023Apply to this trial
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumorsfor Advanced Solid TumorsSites in Nashville +6 more locationsSponsor: LigaChem Biosciences, Inc.Sex: All·Age: 18+Code: NCT05941507·Phase 1, Phase 2·Recruiting·Listed Jul 2023Apply to this trial
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancerfor Breast CancerSites in Nashville +6 more locationsSponsor: SCRI Development Innovations, LLCSex: All·Age: 18+Code: NCT05748834·Phase 2·Recruiting·Listed Mar 2023Apply to this trial